Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben L Da

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Alimentary Pharmacology & Therapeutics|July 9, 2025
Systematic Review: Incidence of Liver-Related Events in People Living With Hepatitis Delta VirusLaura E Telep, Dominique M Roulot, Amanda W Singer, et al.
Euroasian Journal of Hepato-Gastroenterology|December 5, 2022
Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic GraftsBen L Da, Jinendra Satiya, Rajiv P Heda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2025
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis DeltaPietro Lampertico, Pavel O Bogomolov, Vladimir Chulanov, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 9, 2024
Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48Tarik Asselah, Pietro Lampertico, Soo Aleman, et al.
Genes & Cancer|December 19, 2022
Pathogenesis to management of hepatocellular carcinomaBen L Da, Kelly I Suchman, Lawrence Lau, et al.
The New England Journal of Medicine|June 6, 2024
Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis DTarik Asselah, Vladimir Chulanov, Pietro Lampertico, et al.
Journal of Hepatology|May 11, 2024
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trialHeiner Wedemeyer, Soo Aleman, Maurizia Brunetto, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Alimentary Pharmacology & Therapeutics|July 9, 2025
Systematic Review: Incidence of Liver-Related Events in People Living With Hepatitis Delta VirusLaura E Telep, Dominique M Roulot, Amanda W Singer, et al.
Euroasian Journal of Hepato-Gastroenterology|December 5, 2022
Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic GraftsBen L Da, Jinendra Satiya, Rajiv P Heda, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2025
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis DeltaPietro Lampertico, Pavel O Bogomolov, Vladimir Chulanov, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 9, 2024
Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48Tarik Asselah, Pietro Lampertico, Soo Aleman, et al.
Genes & Cancer|December 19, 2022
Pathogenesis to management of hepatocellular carcinomaBen L Da, Kelly I Suchman, Lawrence Lau, et al.
The New England Journal of Medicine|June 6, 2024
Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis DTarik Asselah, Vladimir Chulanov, Pietro Lampertico, et al.
Journal of Hepatology|May 11, 2024
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trialHeiner Wedemeyer, Soo Aleman, Maurizia Brunetto, et al.
Pageof 4